Fast Five Quiz: Non–Small Cell Lung Cancer (NSCLC) and the Epidermal Growth Factor Receptor Gene (EGFR)

Daniel S. Schwartz, MD, MBA

November 30, 2021

Non–small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers and is the leading cause of death from cancer for both men and women worldwide. Mutations in the epidermal growth factor receptor (EGFR) gene of patients with NSCLC are found in about 15% of White populations, 19% of Black populations, and 40%-50% of Asian populations. The most common EGFR gene mutations among those with NSCLC are deletions in exon 19 (45%) and a point mutation in exon 21 (40%).

How much do you know about NSCLC and EGFR? Test your knowledge with this quick quiz.

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Daniel S. Schwartz. Fast Five Quiz: Non–Small Cell Lung Cancer (NSCLC) and the Epidermal Growth Factor Receptor Gene (EGFR) - Medscape - Nov 30, 2021.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.